Canada markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
36.30+0.04 (+0.11%)
At close: 04:00PM EDT
36.30 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.39B
Enterprise Value 1.97B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)255.51
Price/Book (mrq)5.57
Enterprise Value/Revenue 286.43
Enterprise Value/EBITDA -14.18

Trading Information

Stock Price History

Beta (5Y Monthly) 1.56
52-Week Change 315.79%
S&P500 52-Week Change 322.36%
52 Week High 353.18
52 Week Low 322.11
50-Day Moving Average 341.97
200-Day Moving Average 334.32

Share Statistics

Avg Vol (3 month) 3937.44k
Avg Vol (10 day) 3598.58k
Shares Outstanding 565.91M
Implied Shares Outstanding 665.7M
Float 852.74M
% Held by Insiders 10.34%
% Held by Institutions 194.86%
Shares Short (Apr 15, 2024) 46.75M
Short Ratio (Apr 15, 2024) 48.62
Short % of Float (Apr 15, 2024) 411.78%
Short % of Shares Outstanding (Apr 15, 2024) 410.27%
Shares Short (prior month Mar 15, 2024) 45.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 11, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb 11, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-850.33%

Management Effectiveness

Return on Assets (ttm)-21.70%
Return on Equity (ttm)-37.45%

Income Statement

Revenue (ttm)6.88M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)156.10%
Gross Profit (ttm)N/A
EBITDA -139.03M
Net Income Avi to Common (ttm)-141.43M
Diluted EPS (ttm)-2.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)423.6M
Total Cash Per Share (mrq)7.58
Total Debt (mrq)2.54M
Total Debt/Equity (mrq)0.59%
Current Ratio (mrq)13.87
Book Value Per Share (mrq)7.68

Cash Flow Statement

Operating Cash Flow (ttm)-107.29M
Levered Free Cash Flow (ttm)-46.7M